Sellas Life Sciences Group ISLS
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 33 institutions reported holding Sellas Life Sciences Group I (SLS) in their 13F filings, up 3 from Q2 2024. 8 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($2.9M), Anson Funds Management LP ($992K) and Geode Capital Management, LLC ($757K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Sellas Life Sciences Group I
- CUSIP
- 81642T209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $1.2M |
| Exits | 4 | $51K |
All 13F filers, Q2 2024 → Q3 2024: 1,683,136 shares bought and 355,641 shares sold, net +1,327,495 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Vanguard Group Inc. | 0.00% | Add +28.4% | 2,292,857 | $2.9M |
| Anson Funds Management LP | 0.14% | New | 793,835 | $992K |
| Geode Capital Management, LLC | 0.00% | Add +17.1% | 605,191 | $757K |
| BlackRock, Inc. | 0.00% | — | 431,618 | $540K |
| Opus Capital Group, LLC | 0.04% | Add +2.3% | 226,100 | $283K |
| State Street Corp. | 0.00% | Add +30.2% | 174,529 | $218K |
| Diametric Capital, LP | 0.10% | Add +4.7% | 160,194 | $200K |
| Northern Trust Corp. | 0.00% | No change | 100,843 | $126K |
| Renaissance Technologies | 0.00% | Add +186.4% | 92,937 | $116K |
| Virtu Financial LLC | 0.01% | Add +24.1% | 79,241 | $99K |
| XTX Topco Ltd | 0.01% | New | 62,785 | $78K |
| Prelude Capital Management, LLC | 0.01% | Add +4.7% | 58,338 | $73K |
| LPL Financial LLC | 0.00% | No change | 51,894 | $65K |
| Mariner, LLC | 0.00% | Add +5.6% | 47,429 | $59K |
| Citadel Advisors | 0.00% | New | 47,319 | $59K |
| Millennium Management | 0.00% | Reduce -69.2% | 46,335 | $58K |
| Independent Financial Group, LLC | 0.00% | No change | 23,250 | $29K |
| Morgan Stanley | 0.00% | Add +428.8% | 17,435 | $22K |
| Two Sigma Investments, LP | 0.00% | New | 16,591 | $21K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 16,238 | $20K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 15,554 | $19K |
| Calton & Associates, Inc. | 0.01% | New | 14,000 | $18K |
| Equitable Holdings, Inc. | 0.00% | Reduce -94.3% | 12,060 | $15K |
| Nemes Rush Group LLC | 0.00% | No change | 10,000 | $10K |
| JPMorgan Chase & Co. | 0.00% | New | 5,789 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -72.8% | 3,709 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,660 | $2K |
| Bank of America Corp. | 0.00% | Reduce -8.8% | 526 | $658 |
| Jones Financial Companies LLLP | 0.00% | No change | 374 | $471 |
| FMR LLC | 0.00% | New | 187 | $233 |
| Parkside Financial Bank & Trust | 0.00% | No change | 2 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -70.1% | 200 | $0 |
| Cwm, LLC | 0.00% | New | 10 | $0 |
"% of holder's portfolio" is SLS's weight in each manager's 13F, not the share of Sellas Life Sciences Group I the manager owns.